Search Results - "Brezis, Miriam R."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    An old diagnostic tool for new indications: inpatient Holter ECG for conditions other than syncope or stroke by Freund, Ophir, Caspi, Inbar, Alcalay, Idan, Brezis, Miriam R., Frydman, Shir, Bornstein, Gil

    Published in Scientific reports (02-08-2023)
    “…Holter electrocardiography (ECG) assists in the diagnosis of arrhythmias. Its use in the inpatient setting has been described solely for the evaluation of…”
    Get full text
    Journal Article
  2. 2

    Effectiveness and safety of standard chemotherapy in older patients with ovarian cancer: a retrospective analysis by age group and treatment regimen by Brezis, Miriam R, Shachar, Eliya, Peleg Hasson, Shira, Laskov, Ido, Michaan, Nadav, Levy, Bar, Wolf, Ido, Safra, Tamar

    Published in Frontiers in oncology (13-12-2023)
    “…To evaluate the effectiveness and safety of standard chemotherapy administered to patients >70 years with advanced ovarian cancer (OC). Medical records of 956…”
    Get full text
    Journal Article
  3. 3

    Interleukin 23 Produced by Hepatic Monocyte-Derived Macrophages Is Essential for the Development of Murine Primary Biliary Cholangitis by Reuveni, Debby, Brezis, Miriam R, Brazowski, Eli, Vinestock, Philip, Leung, Patrick S C, Thakker, Paresh, Gershwin, M Eric, Zigmond, Ehud

    Published in Frontiers in immunology (13-08-2021)
    “…Primary Biliary Cholangitis (PBC) is an organ-specific autoimmune liver disease. Mononuclear phagocytes (MNPs), comprise of monocyte, dendritic cells and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Next generation sequencing in ovarian cancer patients: Does personalized medicine improve oncological outcomes? by Safra, Tamar, Hershkovizh, Dov, Shachar, Eliya, Adar, Lyri, Brezis, Miriam R., Raviv, Yuval, Galmor, Lee, Peleg Hasson, Shira

    Published in Journal of clinical oncology (20-05-2021)
    “…Abstract only 5553 Background: Ovarian cancer (OC) is the second most common gynecologic malignancy and the most common cause of gynecologic cancer mortality…”
    Get full text
    Journal Article